Want to join the conversation?
$CELG said in addition to the EU, REVLIMID is indicated for treating patients with relapsed/refractory MCL in the US, Switzerland, Israel, Turkey, Australia and some countries in Latin America. REVLIMID is also indicated in some countries including the EU for treating multiple myeloma and myelodysplastic syndromes.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.